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Summary
The crystal structure of a conserved domain of non-
structural protein 3 (nsP3) from severe acute respira-
tory syndrome coronavirus (SARS-CoV) has been
solved by single-wavelength anomalous dispersion
to 1.4 A˚ resolution. The structure of this ‘‘X’’ domain,
seen in many single-stranded RNA viruses, reveals a
three-layered a/b/a core with a macro-H2A-like fold.
The putative active site is a solvent-exposed cleft that
is conserved in its three structural homologs, yeast
Ymx7, Archeoglobus fulgidus AF1521, and Er58 from
E. coli. Its sequence is similar to yeast YBR022W
(also known as Poa1P), a known phosphatase that
acts on ADP-ribose-100-phosphate (Appr-100-p). The
SARS nsP3 domain readily removes the 100 phosphate
group from Appr-100-p in in vitro assays, confirming
its phosphatase activity. Sequence and structure com-
parison of all known macro-H2A domains combined
with available functional data suggests that proteins
of this superfamily form an emerging group of nucleo-
tide phosphatases that dephosphorylate Appr-100-p.
Introduction
Severe acute respiratory syndrome (SARS) emerged as
the first severe and readily transmissible new disease of
the 21st century and caused 8000 infections and more
than 800 deaths in 2003 (Groneberg et al., 2003). The
causative organism is a new coronavirus (SARS-CoV)
that is distantly related to group II coronaviruses. The
virus has a single-stranded RNA genome of w29.7 kb
that encodes at least 14 putative open reading frames
(ORFs) (Peiris et al., 2003; Drosten et al., 2003) (Figure
1A). Two-thirds of the viral genome at the 50 end is orga-
nized as a single highly conserved ORF, known as ORF-
1a/1ab, that is translated into two large polyproteins,
pp1a and pp1ab (Ksiazek et al., 2003). Translation of
pp1ab involves ribosomal frameshifting, a feature also
seen in many other coronaviruses (Baranov et al.,
2005; Snijder et al., 2003). Termed as the ‘‘replicase poly-
proteins,’’ pp1a and pp1ab are subsequently posttrans-
lationally cleaved by two virus-encoded proteases, the
3C-like protease (the main protease or 3CL-Pro) and
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protein products (Snijder et al., 2003) (Figure 1A). These
‘‘nonstructural proteins’’ or nsPs (nsP1–nsP16) form a
giant replicase complex that participates in numerous
functions during viral infection, such as replication of
the RNA genome, processing of subgenomic RNA, and
packaging of newly budding virions (Ziebuhr et al.,
2001).
The third of these nonstructural proteins, nsP3, is
a large multidomain protein of 1922 amino acids that
spans residues 819–2740 of pp1a (NP_828862; gi:
34555776) (Thiel et al., 2003). Mature nsP3 results due
to proteolytic cleavage of pp1a at two sites (818GA819
and 2740GK2741) by the papain-like proteinase (Thiel
et al., 2003). nsP3 has conserved sequence motifs of
six independent domains: (1) an N-terminal glu-rich
acidic domain; (2) an X domain with predicted Appr-100-p
processing activity; (3) a SUD domain (SARS-specific
unique domain); (4) a peptidase C-16 domain that con-
tains the papain-like protease; (5) a transmembrane do-
main; and (6) the Y domain (Figure 1A).
The conserved X domain of nsP3 has been predicted
to house a putative adenosine diphosphate ribose 100
phosphatase (ADRP) function and is annotated in do-
main classification databases such as SMART (Letunic
et al., 2004) and Interpro (Mulder et al., 2003) as a mem-
ber of the A1pp superfamily that includes more than 300
proteins from archaea, bacteria, eukaryotes, and single-
stranded, positive-sense RNA viruses. Structures of
three homologs from this superfamily, yeast Ymx7,
E. coli Er58, and a conserved C-terminal domain of
nonhistone macro-H2A from Archeoglobus fulgidus
(AF1521), show that they all adopt a generic macro-
H2A-like fold with minor variations. While the function
of some members of this superfamily, like the human
poly-(ADP-ribose) polymerase, has been experimentally
characterized (D’Amours et al., 1999), that of many
others is yet to be determined.
As a part of an integrated program to study emerging
infectious diseases, we have undertaken the structural
and functional characterization of all of the major protein
products in SARS-CoV by using a multipronged ap-
proach. This included a detailed bioinformatics analysis
of the SARS-Tor2 genome by using sensitive profile-
based methods like PSI-BLAST (Altschul et al., 1997),
FFAS (Rychlewski et al., 2000), and HMMER (Eddy,
1996) for detection of remote homologs, identification
of domain boundaries in multidomain proteins, and
functional annotation. Based on this analysis, 173 con-
structs that cover the entire proteome were designed
and cloned into vectors for overexpression in E. coli
and baculovirus systems (http://sars.scripps.edu).
In this study, we present the first of the crystal struc-
tures from this effort, that of the highly conserved
putative phosphatase domain of nsP3. To our knowl-
edge, this is the first crystal structure of this domain
from positive-sense, single-stranded RNA viruses. It
reveals a close structural relationship with prototypical
macro-H2A-like fold proteins. One of its sequence
homologs, Poa1p (YBR022) from Saccharomyces
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1666Figure 1. Genomic Location of the X Domain of SARS nsP3
(A) Schematic of the SARS genome and proteome showing the location of SARS nsp3 and its putative functional domains. The predicted func-
tions of different nsPs of ORF1a/ORF1ab are highlighted along with the structural and accessory genes. Abbreviations used are: P65, P65 protein
homolog of murine hepatitis virus; 3CL-Pro, SARS main protease; RdRp, RNA-dependent RNA polymerase; Hel, Zn2+-dependent helicase; ExoN,
homolog of exonuclease; NendoU, uridylate-specific endonuclease; 20-O-MT, methyltransferase; E, small envelope glycoprotein; M, matrix; N,
nucleocapsid; ADRP, ADP-ribose-100-phosphate phosphatase; SUD, SARS-specific unique domain; PL2-Pro, papain-like protease; TM, trans-
membrane domain. (Figure modified from Snijder et al., 2003).
(B) Sequence alignment of known macrodomains. Group I: ADRP domain found in nsPs of different coronaviruses: Sars_nsP3, SARS corona-
virus-Tor2; R1AB_CVBM, bovine coronavirus; AAR01012, human coronavirus OC43; Q66WN5, murine hepatitis virus; Q6Q1S3, human corona-
virus NL63; R1AB_PEDV7, porcine epidemic diarrhea virus; R1AB_CVPPU, transmissible gastroenteritis virus; R1AB_IBVBC, avian infectious
bronchitis virus. Group II: ADRP homologs from other related viruses: Q6X2U4, rubella virus; O90370, Igbo Ora virus; Q8JUX6, Chikungunya vi-
rus; O10380, Semliki forest virus; Q8QHM4, Mayaro virus; Q9JGK9 Ross River virus; P87515, Barmah forest virus; Q87644, Sindbis virus; Q86924,
Aura virus; Q88791, Western equine encephalomyelitis virus; Q66580, Eastern equine encephalitis virus; O90163, Venezuelan equine encepha-
litis virus; Q8QL53, sleeping disease virus; O90368, O’nyong-nyong virus; Q8JJX1, salmon pancreatic disease virus; and Group III: macrodomain
hypothetical proteins of the A1pp superfamily: gi|20178242, E. coli ymdB; gi|20178260, Deinococcus radiodurans; gi|20178146, Ralstonia sola-
nacearum; gi|20178157, Mesorhizobium loti; gi|20178167, Pseudomonas aeruginosa; gi|20090472, Methanosarcina acetivorans; gi|20178156,
Thermoplasma volcanium; gi|16082127, Thermoplasma acidophilum; gi|19705253, Fusobacterium nucleatum; gi|20178176, Pyrococcus abyssi;
gi|20178181, Pyrococcus horikoshii; gi|11499116, Archaeoglobus fulgidus (AF1521); gi|20178224, Pyrobaculum aerophilum; gi|20178255, Sulfo-
lobus solfataricus; gi|20178177, Thermotoga maritima; gi|20094386, Methanopyrus kandleri; gi|20178182, Aquifex aeolicus; gi|20178236, Aero-
pyrum pernix; gi|20178237, Mycobacterium tuberculosis. The two structurally characterized members of group III are highlighted in red.cerevisiae, was recently functionally characterized as
a highly specific phosphatase that removes the 100
phosphate group of ADP-ribose-100-phosphate (Appr-
100-p) in the latter half of the tRNA splicing pathway
in yeast (Shull et al., 2005), hinting at a similar substrate
specificity for SARS ADRP. Using an in vitro assay, we
experimentally validate that this ADRP domain of SARS
nsP3 is indeed a phosphatase that removes the ter-
minal 100 phosphate from Appr-100-p. To our knowl-
edge, these results, combined with recently elucidated
structures of two hypothetical proteins, suggest that amajority of macro-H2A fold members form a new fam-
ily of nucleotide phosphatases.
Results and Discussion
Description of the ADRP Domain of SARS nsP3
The cloned insert contains 182 residues from nsP3 of
SARS-CoV-Tor2 and has a monomer molecular weight
of 19,523 Da and a pI of 6.9. The final structural model re-
fined against crystallographic data to 1.4 A˚ resolution
has four subunits in the asymmetric unit in very similar
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1667conformations (rmsds < 0.4 A˚ for 166 Ca atoms). We do
not observe electron density for a few residues at the C
terminus of each of the four monomers. These include 5
residues in chain D, 15 residues in the chain A, and 9 re-
sidues each in the B and C monomers. The final refine-
ment statistics and stereochemical parameters of the
structure are listed in Table 1. Overall, each subunit con-
sists of eight b strands and six a helices (Figure 2A).
Strands 2–8 form a central seven-stranded b sheet that
has a strand order of 2387465. The outermost strands
on either side are antiparallel to the rest. The six helices
straddle the central b sheet to form a three-layered a/b/
a topology. Two of the subunits in the asymmetric unit
form a loosely packed head-to-head dimer (Figure 2B).
A short loop connecting strand 6 and helix H4 is involved
in weak interfacial contacts with the conserved Gly-rich
segment of the other monomer. The interface is fairly
small at w870 A˚2 (435 A˚2 per monomer) and predomi-
nantly nonpolar (60%). Residues that form the putative
active site lie close to the dimer interface. The enzyme
elutes as a homodimer in gel-filtration studies (data
not shown), indicating that the physiologically relevant
form of this protein may be dimeric.
Table 1. Data Collection and Refinement Statistics
SeMet (Peak l) Native
Data Collection
Space group P212121 P212121
Unit cell parameters a = 76.920 A˚,
b = 81.224 A˚,
c = 125.695 A˚
a = 76.495 A˚,
b = 81.585 A˚,
c = 125.465 A˚
Wavelength (A˚) 0.97941 0.9794
Resolution range (A˚) 50.0–2.2 50.0–1.40
Number of observations 1,909,845 2,836,583
Number of unique
reflections
41,023 145,609
Completeness (%) 100.0 (99.8) 99.20 (98.9)
Redundancy 7.6 3.7
Mean I/s (I) 30.13 (6.04) 32.93 (2.82)
Rsym
a on I 0.091 (0.507) 0.043 (0.590)
Highest resolution shell (A˚) 2.24–2.20 1.42–1.40
Figure of merit after
RESOLVE
0.54
Refinement
Rwork
b 16.4 (22.2)
Rfree
c 19.0 (25.0)
Protein atoms
(average B factor)
5,485 (18.1)
Solvent atoms
(average B factor)
950 (36.91)
Hetero atoms
(average B factor)
72 (35.28)
Rmsd bond length (A˚) 0.018
Rmsd bond angle (º) 1.69
Ramachandran statistics
Most favored (%) 90.8
Additionally allowed (%) 8.4
Generously allowed (%) 0.8
a Rsym = Shkl[(Sj|Ij 2 <I>|)/Sj|Ij|].
b Rwork = Shkl |Fo2 Fc|/Shkl|Fo|, where Fo and Fc are the observed and
calculated structure factors, respectively.
c 5% of the reflections (7,683 reflections) was used in the calculation
of Rfree.
Values in parentheses are for data corresponding to the outermost
shell.SARS ADRP Belongs to the Macro-H2A Fold
Comparison of one of the chains of SARS ADRP against
all known structures in the PDB by using DALI (Holm and
Sander, 1993) revealed the presence of two structural
homologs: a hypothetical protein from Archeoglobus
fulgidus, AF1521 (PDB code: 1HJZ; z score of 18.1;
rmsd of 2.4 A˚ for 152 superimposed Ca atoms; pairs
with a z score > 3.0 are considered structurally similar),
Figure 2. Structure of SARS ADRP
(A) Ribbon representation of the SARS nsP3 ADRP monomer. The
two glycine-rich loops are shown in yellow. Secondary structures
are colored from blue (N) to red (C terminus). Helices are numbered
H1–H6, and b strands are numbered from 1 to 8.
(B) The SARS ADRP dimer observed between the B and D subunits
in the asymmetric unit. The four conserved segments are colored
red in each subunit; the conserved histidines and asparagines at
the active site are shown as ball-and-sticks.
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(A–F) (A) Bovine Lens Leu-aminopeptidase (1LAM). (B) E. coli PepA (1GYT). (C) yeast Appr phosphatase homolog (1TXZ). (D) E. coli hypothetical
protein Er58 (1SPV). (E) Archeoglobus fuldiges AF1521. (F) ADRP domain of SARS nsp3. The helices are colored cyan, and the strands are col-
ored yellow in the core macrodomain. The inserted secondary structural elements that are not part of the main core are highlighted in red. The
circular permutation seen in yeast Ymx7 (1TXZ) is marked in green, and the C-terminal helical domain is shown in white.and the N-terminal domain of bovine lens leucine amino-
peptidase (PDB code: 1LAM; z score of 8.0; rmsd of 2.6 A˚
for 119 Ca atoms; Stra¨ter and Lipscomb, 1995). Both
structures are members of the ‘‘macrodomain-like’’
fold as defined in the SCOP database (Murzin et al.,
1995). This fold includes two other structural homologs
fromE. coli, aminopeptidase A (PepA) and a hypothetical
protein ymbD (Northeast Structural Genomics Consor-
tium target Er58; PDB code: 1SPV). The topological con-
nectivity of the secondary structural elements of these
four proteins along with the ADRP domain of SARS
nsP3 is shown in a similar orientation in Figure 3 (A, B,
D, E, and F). All of them share the same three-layered
a/b/a core, with minor variations. They have a mixed
b sheet of six strands with strand order 165243. The first
strand and the first helix are absent in bovine lens leucine
aminopeptidase (BlLAP, Figure 3A). AF1521 has two in-
sertions to this core, a b strand inserted at the N terminus
and an a helix between strands 3 and 4 (Figure 3E). The
SARS ADRP domain has two b strands inserted at the
N terminus, one of which forms part of the central b sheet
(Figure 3F). The sixth protein structure in Figure 3, Ymx7
from yeast (PDB code: 1TXZ), is a member of this fold
and has a circular permutation (Figure 3C). The first
strand and the first helix of this protein occupy structural
positions that correspond to the last b strand and the
C-terminal helix (H6) of a canonical macro-like fold.
Function of Macro-like Fold Proteins
BlLAP is an exopeptidase that cleaves amino acids from
the N terminus of polypeptides (Burley et al., 1990).
E. coli PepA is a DNA binding protein that is involved
in Xer site-specific recombination and transcriptional
control of the carAB operon (Stra¨ter et al., 1999). Al-
though both share significant similarities in sequence(31% identity) and structure (both are homohexameric
with a dinuclear Zn2+ in their active site), they have
widely different functions. The peptidase activity is not
needed by PepA to function during Xer-specific recom-
bination (McCulloch et al., 1994) or during repression of
carAB transcription (Charlier et al., 1995). On the other
hand, blLAP does not have any demonstrated DNA
binding function.
AF1521 is a stand-alone macrodomain from Archeo-
globus fulgidus and is a close homolog of the C-terminal
nonhistone domain of the largest variant of histone H2A
(Pehrson and Fried, 1992; Pehrson and Fuji, 1998). It is
evolutionarily related to P loop-containing nucleotide tri-
phosphate hydrolases. The structure has been solved in
its apo form (Allen et al., 2003) and in complex with two
ligands, Mg2+-ADP (PDB code: 2BFR, unpublished)
and ADP-ribose (PDB code: 2BFQ; unpublished). Yeast
Ymx7 is a conserved hypothetical protein from the
ADH3-RCA1 intergenic region. Although its function has
not been experimentally demonstrated, it has been an-
notated as an ADP-ribose-100-monophosphatase (ADRP)
based on its sequence similarity to known ADRPs (Ku-
maran et al., 2005). Finally, the structure of a conserved
hypothetical protein, Er58, from E. coli that was solved
by the Northeast Structural Genomics Consortium (PDB
code: 1SPV, unpublished) reveals a canonical macro-
like fold. Its function remains unknown.
It would thus appear that the five known members of
this fold fall into two broad functional groups, one con-
taining BlLAP and E. coli PepA and the second contain-
ing the other three hypothetical proteins. All members of
the second group not only share a similar global archi-
tecture, but also share conserved active site features.
Although all of these proteins can be picked up by
PSI-BLAST by using SARS ADRP as a query template,
Structure of ADRP Domain of SARS nsP3
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ADRP with YMX7 and AF1521
(A) Surface of SARS ADRP showing the distri-
bution of electrostatic potential. The ADP-
ribose bound complexes of AF1521 (PDB
code: 2BFQ; 1.5 A˚) and Yeast Ymx7 (PDB
code: 1TXZ; 2.0 A˚) are shown for comparison.
The bound ligands in the two structures are
shown as ball-and-sticks.
(B) Superposition of the three structures
(SARS ADRP is in green, AF1521 is in cyan,
and Ymx7 is in purple). The bound ADP and
ADP-ribose are shown as ball-and-sticks.
The residues from SARS ADRP that are pro-
posed to interact with the ligand are shown
in ball-and-sticks, and the putative interac-
tions are highlighted as dotted lines.
(C) Structure-based sequence alignment of
SARS ADRP with its four structure homologs:
AF1521 ADP-ribose complex (2BFQ); E. coli
hypothetical protein Er58 (1SPV); E. coli
PepA (1GYT); and yeast Ymx7 ADP-ribose
complex (1TXZ). Helical regions are in cyan,
and b strands are in yellow. Regions that
can be confidently aligned are in capital let-
ters, and those that align poorly or do not
align at all are in small letters. The four con-
served segments are highlighted in rectangu-
lar blocks. The circular permutation of yeast
Ymx7 is marked in red.it is clear that the SARS domain is closer to phospha-
tases of the second group.
The Putative Active Site
The ADRP domain of SARS nsP3 has a deep solvent-
exposed cleft on the protein surface that is very similar
to that seen in AF1521, yeast Ymx7, andE. coliEr58. Sur-
face representations showing the distribution of electro-
static potential on SARS ADRP and on the structures of
ligand bound forms of AF1521 and yeast Ymx7 (shown in
Figure 4A) clearly indicate that the putative active site
cleft is similar in the three structures. Repeated soaking
and cocrystallization attempts failed to yield cocrystals
of SARS ADRP with ADP-ribose, perhaps because the
active site is occluded by the dimer interface. However,the availability of the product (ADP-ribose) bound forms
of AF1521 and yeast Ymx7 facilitates a detailed struc-
ture comparison of these two homologs with SARS
ADRP. Many of the residues that interact with the ligand
are conserved in the three structures. A view of the pro-
posed active site of SARS ADRP along with the superim-
posed structures of AF1521 and yeast Ymx7 are shown
in Figure 4B, highlighting the interactions that are likely
between residues of the protein with the ligand. A
structure-based sequence alignment of SARS ADRP
with four of its structural homologs is shown in Figure
4C. The BlLAP sequence was omitted in this alignment.
Most macro-like fold proteins, including the ADRP do-
main from RNA viruses, show the presence of four con-
served stretches of residues (Figure 1B). The first motif
Structure
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acids, is highly conserved across the superfamily. This
is immediately followed by a Gly-rich region (GGGVAG)
that is reminiscent of the Walker A motif seen in many
P loop nucleotide hydrolases (Walker et al., 1982). A no-
table feature is that the invariant lysine of the Walker A
motif is an arginine in some coronaviruses and is absent
in others (Figure 1B). The third stretch, ‘‘XVVGP,’’ where
X is often a conserved histidine, is in the middle of the
polypeptide. Finally, a stretch of 4 residues mainly con-
sisting of small hydrophilic amino acids and a glycine is
present near the C terminus of the polypeptide chain
(Figure 1B). Residues from the third motif occupy struc-
turally similar positions to the Walker B motif in classical
P loop hydrolases. These four regions line the putative
active site of the ADRP domain of the SARS nsP3 struc-
ture. The first motif forms part of the fourth b strand (Fig-
ure 4C), while the Gly-rich segment is part of a loop that
connects strand 4 with the second helix. The third motif
connects strand 6 to helix H4.
Description of the Putative Active Site of SARSADRP
The active site can be broadly divided into the adenine
binding cleft, the first ribose, and the bisphosphate
binding site, followed by the terminal ribose-phosphate
binding pocket that is the center of catalysis. As antici-
pated, the adenine binding pocket consists of largely
hydrophobic residues. It is less conserved in the three
structures than the other two pockets. In SARS ADRP,
residues Ile23, Ala52, Pro125, and Ala154 form the walls
of the putative adenine binding cleft. In the AF1521-
ADP-ribose complex structure, the adenine ring is stabi-
lized by two hydrogen bonds. One of the side chain
carbonyl oxygens of Asp20 is within hydrogen bonding
distance to the N1 and N6 of the adenine rings. In
SARS ADRP, the equivalent residue is Asp22 and is
likely to play a similar role. The other hydrogen bond is
between the N7 and the backbone carbonyl group of
Gly42. The binding site of the first ribose ring is a highly
hydrated solvent-exposed cleft in which multiple water-
mediated interactions are seen between the ribose and
residues Asp177 and Ser180 in AF1521. In SARS
ADRP, residues Asn156 and Asp157 that lie in a loop be-
tween strand 6 and helix H6 are likely to stabilize the ri-
bose by forming similar polar interactions.
The a and b phosphates of the ADP moiety are mainly
stabilized by backbone hydrogen bonds with the two
Gly-rich motifs in a manner similar to that observed in
P loop hydrolases. While the a phosphate is stabilized
by hydrogen bonds with the backbone of the three con-
secutive glycines of motif II, the b phosphate interacts
with the amides of Gly130 and Ile131. This loop also
helps to stabilize the b phosphate, as the Walker B motif
does in P loop hydrolases.
The terminal ribose moiety of the ADP-ribose-100-
phosphate lies on a cleft that is approximately perpen-
dicular to the adenine binding pocket. This is the puta-
tive site of catalysis. The side chain amide nitrogen of
the conserved asparagine (N80) forms hydrogen bonds
with the O3 and O4 of the ribose in the yeast Ymx7-ADP-
ribose complex (Figure 4D). This residue from the first
motif superimposes almost perfectly with Asn40 in
SARS ADRP and Asn34 in AF1521 and is invariant
among all macro-like fold members (Figure 1B). Asp90and His145, two residues that have been implicated in
catalysis in yeast Ymx7, lie embedded underneath the
loop that connects strand 4 and helix H2 (Figure 4D).
Enzymatic Activity of SARS ADRP
Given the close similarity between the three structures
(SARS ADRP, AF1521, and Ymx7) and the similarity
at the sequence level between SARS ADRP and yeast
Poa1p (an enzyme with demonstrated ADRP activity),
it was apparent that their function was likely to be similar
as well. We therefore tested the ability of SARS ADRP to
dephosphorylate Appr-100-p in vitro. We employed a ge-
neric assay that monitors the liberation of inorganic
phosphate in solution during catalysis (Webb, 1992).
The results are shown in Figure 5. We observed a sus-
tained release of phosphate after the addition of in-
creasing amounts of the substrate (Appr-100-p) to the as-
say containing fixed amounts of the enzyme (Figure 5A).
Upon overnight incubation, the amount of phosphate re-
leased was proportional to the amount of the substrate
added, suggesting that SARS ADRP indeed had the abil-
ity to dephosphorylate Appr-100-p into ADP-ribose and
inorganic phosphate (Figure 5B). Further kinetic charac-
terization of the enzyme shows that the dephosphoryla-
tion is relatively low, with a KM of 52.76 8.2 mM and a kcat
of 5.19 min21. While the observed catalytic efficiency of
this enzyme is not very high, it is comparable to the val-
ues reported for Poa1p. In a TLC-based assay with ra-
diolabeled substrates, both Poa1p and Hal2p, a known
30 phosphatase of 50,30-pAp, showed similar low cata-
lytic yields (KM = 2.8 mM; kcat = 1.7 min
21 for Poa1p),
but both enzymes were highly specific for the Appr-100-p
substrate (Shull et al., 2005). A few well-known phos-
phatases whose activity has been monitored by the
same assay (Wang et al., 1995) also show similar levels
of activity.
There might be multiple reasons for the low activity
levels detected in these assays. It might be intrinsic
for this class of enzymes, as seen in the case of yeast
Poa1p. Moreover, the released product, ADP-ribose, is
a competitive inhibitor of this reaction (Shull et al.,
2005). The proposed active site is occluded at the dimer
interface in the crystal structure (Figure 2B) and might be
hindering access to the substrate in our in vitro assay.
The in vivo scenario might be different, where enzyme
activity might be regulated by other components of the
replicase complex.
Catalytic Mechanism
Yeast Ymx7, one of the structural homologs of SARS
ADRP, has been proposed to perform the same reac-
tion. It is a remote homolog of the macrodomain super-
family, albeit with a circular permutation (Figure 3C). It
also has a different set of catalytic residues at the active
site when compared to classical macrodomains. Based
on the structure of the ADP-ribose bound Ymx7, Ku-
maran et al. (2005) have speculated on a catalytic mech-
anism that involves three residues: Asp90, His145, and
Asn80. While the histidine and asparagine residues are
conserved in all three of the structures, Ymx7, AF1521,
and SARS nsP3, the equivalent position of Asp90 of
Ymx7 is an alanine in the other two (Ala50 in ADRP and
Ala44 in AF1521-ADP-ribose complex; Figure 4D). This
would imply that while the proposed mechanism might
Structure of ADRP Domain of SARS nsP3
1671Figure 5. Enzymatic Activity of the SARS ADRP Domain
(A) Continuous release of inorganic phosphate monitored by an in-
crease in absorbance for the initial 20 min of the reaction in two sub-
strate concentrations.
(B) Amount of phosphate released at three different substrate con-
centrations after overnight incubation with 5 mM enzyme when incu-
bated with three different concentrations of the substrate. The error
bars correspond to the standard deviations of three independent
measurements at each concentration.
(C) Michaelis-Menton kinetics (rate plot) showing the activity of the
enzyme at different concentrations of the substrate (Appr-100-p)
and the obtained values of KM and kcat.be correct in the case of yeast Ymx7, it cannot be the
mode of dephosphorylation for either ADRP or AF1521.
Instead, these two enzymes have a histidine (His45 in
ADRP and His39 in AF1521) residue that might be in
close proximity to the terminal 100 phosphate of the sub-
strate and might therefore be involved in catalysis. Alter-
nately, it might be speculated that the role of the pre-
dominant nucleophile might be played by one of the
aspartates or glutamates from the loop 101NAGEDIQ107
in SARS and other coronaviral ADRPs. This loop shows
large conformational changes in the apo and ligand
bound forms of AF1521 and Ymx7 and is rich in acidic
residues (Figure 1B). Further mechanistic studies, co-
crystallization experiments, and mutagenesis of these
residues that are implicated here are necessary to eluci-
date the catalytic mechanism of this enzyme. Despite re-
peated attempts at soaking and cocrystallization, we
have not been able to observe density of the bound sub-
strate. A possible reason might be the limited accessibil-
ity of the active site, as it is buried in the dimer interface
during crystal packing (Figure 2B).
Discussion
The demonstrated function of SARS ADRP as an Appr-
100-p phosphatase has important functional implications
in the SARS life cycle. While the manner in which the vi-
rus infects the human host is fairly well characterized,
many of the postinfection events that occur in the intra-
cellular milieu of the host remain poorly understood. The
infection process begins when the spike glycoprotein
present on the viral coat recognizes one of two recep-
tors present on the human cell surface: angiotensin-
converting enzyme-2 (ACE-2) (Li et al., 2003; Kuhn
et al., 2004) or a C-type lectin known as L-SIGN or
CD209L (Jeffers et al., 2004). In arteri- and coronavi-
ruses, an early postinfection event is the transcription
of a nested set of subgenomic RNA (Lai and Holmes,
2001; Thiel et al., 2003). The resulting mRNAs contain
a short 50-terminal ‘‘leader’’ sequence derived from the
50 end of the genome. The fusion of the two noncontigu-
ous RNA segments is achieved by a discontinuous step
in the synthesis of the minus strand and involves tran-
scription regulatory sequences or TRSs (Thiel et al.,
2003; Pasternak et al., 2001). Very few experimental de-
tails exist on the processing, maturation, and subse-
quent roles of these important molecules in the viral
life cycle.
This process has parallels in the eukaryotic tRNA
splicing pathway that has been well studied in yeast
and plants (Culver et al., 1994; Phizicky and Greer, 1993;
Peebles et al., 1983). In these organisms, pre-tRNA
splicing is initiated by cleavage at the splice site by an
endonuclease. The resulting tRNA halves are then li-
gated to yield mature tRNA that retains the 20 phospho-
monoester group at the splice site (Phizicky and Greer,
1993; McCraith and Phizicky, 1990). Using NAD as an
acceptor, a phosphotransferase removes the 20 phos-
phate to yield ADP-ribose-100-200 cyclic phosphate or
Appr>p (Culver et al., 1993). A cyclic phosphodiesterase
hydrolyzes Appr>p to yield Appr-100-p (Culver et al.,
1994; Martzen et al., 1999). The terminal step in this
pathway is a phosphatase-catalyzed conversion of
Appr-100-p into ADP-ribose and inorganic phosphate,
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pathways.
There is increasing evidence that the NendoU (nsP15)
in SARS functions in a manner analogous to the endonu-
clease of the tRNA splicing pathway. It is a Mn2+-depen-
dent enzyme that also releases products with 200-300
cyclic phosphorylated ends (Ivanov et al., 2004; Bhard-
waj et al., 2004). While work on this enzyme was in prog-
ress, the eukaryotic homolog of NendoU, the XendoU
from Xenopus laevis, was functionally characterized,
highlighting the existence of an orthologous pathway
in higher eukaryotes (Gioia et al., 2005). Details of this
process are only beginning to emerge. It is noteworthy
that, although orthologs of cyclic phosphodiesterase
(CPD), the enzyme that catalyzes the previous step in
the tRNA splicing pathway, has been found in group II
coronaviruses along with toro- and rotaviruses, it is ab-
sent in the SARS virus (Thiel et al., 2003).
SARS NendoU specifically recognizes uridylate bases
at GUU sites of RNA (Ivanov et al., 2004). The virus pro-
tects its own RNA by methylating its 50 termini CAP by
using an Ado-Met-dependent RNA methyltransferase
(von Grotthuss et al., 2003), a process that is imperative
during coronaviral replication and an active area of ther-
apeutic intervention (Bach et al., 1995; Vlot et al., 2002).
The possibility that SARS ADRP, NendoU, and the meth-
yltransferase might be acting in concert and might
therefore be functionally linked has been the subject of
previous speculation (Thiel et al., 2003). The precise
role of these three enzymes along with 30-50 exonuclease
and RNA polymerase and their possible interaction with
each other as integral components of the replicase com-
plex remain poorly understood. It is becoming increas-
ingly clear that coronaviruses not only differ from other
related viruses in having a bigger genome size, but
they also have an uncanny similarity with DNA-based
life forms in their ability to maintain, synthesize, and reg-
ulate the proteomic and genomic components of their
life cycle in hitherto unforeseen ways. The work pre-
sented here further reinforces this view and hints at
the possibility of a tRNA splicing pathway-like process
by which the generation of subgenomic RNA and its
subsequent translation to yield mature viral proteins is
regulated.
Orthologs of SARS ADRP are found embedded in non-
structural proteins of many related ssRNA viruses, espe-
cially in alphaviruses of togaviridae (group II of Figure
1B). These include, among others, nsP2 of Sindbis virus
(Strauss et al., 1984), nsP3 of O’nyong-nyong virus (Lan-
ciotti et al., 1998), nsP3 of Ross River virus (Shirako and
Yamaguchi, 2000), P150 of the lone nsP in Rubella virus
(Zheng et al., 2003), nsP3 of Mayaro virus (Anderson
et al., 1954), and nsP3 of Semliki Forest virus (Tuittila
et al., 2000). Many of these viruses have a greatly re-
duced genome size (w10 kb), with only about 4–5
ORFs. On the other hand, the five known human corona-
viruses, HCoV-OC43, HCoV-229E, HCoV-NL63, HCoV-
HKU1, and SARS-CoV, have genome sizes of 27–32
kb. The occurrence of this phosphatase as part of their
replicative machinery underscores the importance of
this enzyme in their life cycle and hints at a similar mech-
anism by which their genomic and subgenomic RNA
could be processed inside their respective host cells.
However, given the greatly reduced proteome size andreliance of some togaviridae members on host enzymes
to meet their replication needs, this process may be
somewhat different from that seen in SARS and the
other human coronaviruses.
Conclusions
To our knowledge, this study provides the first structural
characterization of a highly specific phosphatase from
an RNA virus. The experimental demonstration of phos-
phatase activity on Appr-100-p, combined with its struc-
tural relationship with other known macro-fold members,
strongly hints at the possibility that many ‘‘hypothetical’’
proteins of this superfamily might in fact be phospha-
tases that act on similar substrates. The unique differ-
ences between the active site of SARS ADRP and yeast
Ymx7, both of which dephosphorylate the same sub-
strate, imply that, while being structurally and function-
ally homologous, they probably employ different cata-
lytic mechanisms. Further studies are needed to fully
explore the functional significance of this enzyme in the
larger context of the membrane bound replicase com-
plex and its regulation of translation and replication of
viral RNA. If true, the functional link between SARS
ADRP and other nsPs highlighted here could provide
new avenues for investigation of the replication process
of the virus in infected cells, with the hope of developing
therapeutic agents aimed at inhibiting viral replication.
Experimental Procedures
Cloning, Expression, and Purification
The sequence corresponding to residues 184–365 (182 aa) of SARS
nonstructural protein nsP3 (gi:34555776; NP_828862) of poly-pro-
tein pp1a was amplified by polymerase chain reaction (PCR) from
genomic cDNA of SARS-Tor2 strain with Taq polymerase and primer
pairs encoding the predicted 50 and 30 ends (forward: 50-CCAGTTAA
TCAGTTTACTGGTTATTTAAAACTTACTGAC-30; reverse: 50-CTCCT
CTTGTTTAGGTGCTTCC-30). The PCR product was cloned into
plasmid pMH1f, which encodes an expression and purification tag
(MGSDKIHHHHHH) at the amino terminus. Protein expression was
performed on a sequence-verified clone in native 2xYT or selenome-
thionine (SeMET)-containing media by using the E. coli methionine
auxotrophic strain DL41. Bacteria were lysed by sonication in lysis
buffer (50 mM KPO4 [pH 7.8], 300 mM NaCl, 10% glycerol, 5 mM im-
idazole, two Roche EDTA-free protease inhibitor tablets) with 0.5
mg/ml lysozyme. Cell debris was clarified by ultracentrifugation at
45,000 rpm for 20 min (4ºC), and the soluble fraction was applied
onto a metal chelate column (Talon resin charged with cobalt; Clon-
tech). The column was washed in 20 mM Tris (pH 7.8), 300 mM NaCl,
10% glycerol, 5 mM imidazole and was eluted with 25 mM Tris (pH
7.8), 300 mM NaCl, 150 mM imidazole. The resultant protein was fur-
ther purified by using anion exchange chromatography on a Poros
HQ column with elution buffer containing 25 mM Tris (pH 8.0) and
1 M NaCl. The pure fractions of the protein were pooled, and the
buffer was exchanged into crystallization buffer (10 mM Tris [pH
7.8], 150 mM NaCl) and concentrated by centrifugal ultrafiltration.
The final concentration of native and SeMET protein was 1.0 mM
and 1.4 mM, respectively. The protein was either frozen in liquid ni-
trogen for later use or used immediately for crystallization trials.
Crystallization and Data Collection
The protein was crystallized with the nanodroplet vapor diffusion
method (Santarsiero et al., 2002) by using standard JCSG crystalli-
zation protocols (Lesley et al., 2002). Thick, rectangular, rod-like
crystals (w200 mm 3w100 mm 3w75 mm) appeared after 10 days
in 0.4 ml drops containing 0.2 ml each of protein and crystallization
well solution containing 1.5 M sodium malonate (pH 7.0). A higher
concentration (1.8 M) of sodium malonate with 25% glycerol was
used as cryoprotectant. A native 1.4 A˚ dataset (at a wavelength
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1673of 0.9794 A˚) was collected at beamline 11.1 of the Stanford Syn-
chrotron Radiation Laboratory by using Blu-ICE (McPhillips et al.,
2002). Anomalous diffraction data were collected at the Advanced
light Source (ALS, Berkeley, CA) on beamline 8.2.1 at a wavelength
of 0.97941 A˚, corresponding to the peak wavelength of a selenium
SAD experiment. Reflections were indexed in a primitive orthorhom-
bic lattice (Space group P212121), integrated, and scaled by using
the HKL2000 suite (Otwinowski and Minor, 1997).
Structure Determination and Refinement
The initial phases were obtained by the single wavelength anoma-
lous dispersion (SAD) phasing method with data collected to 2.2 A˚
at the selenium peak wavelength by using the program SOLVE (Ter-
williger and Berendzen, 1999). All 12 selenium sites were located,
and the resulting phases had a figure of merit of 0.54 after density
modification procedures by using RESOLVE (Terwilliger, 2003).
The resultant phases from SAD were merged, improved, and ex-
tended for a native data set to 1.4 A˚ by using the programs CAD
and DM as implemented in the CCP4 package (CCP4, 1994) assum-
ing four monomers in the ASU with Matthews coefficient 2.6 and
a solvent content of 51% (Cowtan, 1994). Automated model building
with Arp/wARP (ver 6.0; Lamzin and Wilson, 1997) tracedw80% of
the backbone and docked 65% of the sequence, including the side
chains. The rest of the sequence was manually built into the density
with O (Jones et al., 1991) and was refined against the high-resolu-
tion native data to 1.4 A˚ with iterative rounds of model building and
refinement by using Refmac5 (Murshudov et al., 1997) of CCP4.
Although RESOLVE did identify the presence of NCS among the
monomers, it was not used at any stage of refinement. A summary
of data collection and refinement statistics is shown in Table 1.
The stereochemical quality of the final refined model was checked
with Procheck (Laskowski et al., 1993), and the dimer interface
was calculated by using the protein-protein interaction server. The
ribbon diagrams were made with Pymol (DeLano, 2002).
Enzyme Assays
The substrate Appr-100-p was a kind gift from Prof. Phyzicky
(Rochester Univ, USA) and was enzymatically prepared by reacting
the precursor Appr>p with cyclic phosphodiesterase (CPD) by using
procedures described in Shull et al. (2005). Phosphate release was
monitored by the Enzchek assay (Molecular Probes Inc, Eugene
OR, USA) by following the manufacturer’s instructions. The assay
uses the method of Webb (1992), which monitors the release of
inorganic phosphate by coupling the phosphatase reaction with
the enzymatic conversion of 2-amino-6-mercapto-7-methyl-purine
riboside (MESG) to 2 amino-6-mercapto-7-methyl purine and
ribose-1-phosphate by purine nucleoside phosphorylase. The sub-
strate MESG has an absorbance maximum of 330 nm, whereas
that of the product is 360 nm. Each 1 ml reaction mixture contains
50 mM Tris (pH 7.5), 1 mM MgCl2, 0.1 mM sodium azide, 200 mM
MESG, 1 U purine nucleoside phosphorylase, and 2.7 mM enzyme.
Increasing amounts of the substrate were added to the reaction
mixture, and the ADRP reaction was monitored by changes in ab-
sorbance at 360 nm in a UV spectrophotometer. To check for phos-
phate contamination, appropriate control reactions were performed
in the presence of enzyme, but with no substrate and vice versa. No
measurable phosphate contamination was detected either from the
enzyme preparation, substrate degradation, or from the buffers. The
assay components were checked with known amounts of phos-
phate standard supplied by the manufacturer. A molar extinction co-
efficient of 11,000 M21 cm21 of the product of the PNP reaction at
360 nm was used to quantitate the amount of released inorganic
phosphate (Etzkorn et al., 1994).
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